Etoposide trials for Extensive-stage Small Cell Lung Cancer (ES-SCLC)

All Etoposide trials · All Extensive-stage Small Cell Lung Cancer (ES-SCLC) trials

Phase breakdown

Recruiting trials studying Etoposide for Extensive-stage Small Cell Lung Cancer (ES-SCLC)

• A Study of Ivonescimab in First-Line ES-SCLC
  NCT07245446 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 3 locations
• Atezolizumab and Rechallenge Chemotherapy in Relapsed Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC).
  NCT06663098 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 25 locations
• Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer
  NCT07061535 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations

Common questions

How many trials study Etoposide for Extensive-stage Small Cell Lung Cancer (ES-SCLC)?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.